FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

25 results

ilaris
(canakinumab)
Novartis Pharmaceuticals Corporation
Usage: ILARIS (canakinumab) is indicated for treating autoinflammatory Periodic Fever Syndromes, including CAPS, TRAPS, HIDS/MKD, and FMF; active Still's Disease in patients 2 years and older; and symptomatic treatment of gout flares in adults when other treatments are unsuitable.
inveltys
(loteprednol etabonate)
ALCON LABORATORIES, INC.
Usage: INVELTYS is a corticosteroid indicated for reducing post-operative inflammation and pain after ocular surgery.
krystexxa
(pegloticase)
Horizon Therapeutics USA, Inc.
Usage: KRYSTEXXA (pegloticase) is indicated for treating chronic gout in adult patients who are refractory to conventional therapy, meaning they have not achieved normalized serum uric acid levels or adequately controlled symptoms with maximum doses of xanthine oxidase inhibitors. It is not recommended for asymptomatic hyperuricemia.
lotemax sm
(loteprednol etabonate)
Bausch & Lomb Incorporated
Usage: LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38% is indicated for the treatment of post-operative inflammation and pain after ocular surgery.
lupkynis
(Voclosporin)
Aurinia Pharma U.S., Inc.
Usage: LUPKYNIS is indicated for the treatment of adult patients with active lupus nephritis (LN) in combination with a background immunosuppressive therapy. Its safety and efficacy have not been established with cyclophosphamide, and its use in this context is not recommended.
lyrica
(PREGABALIN)
Parke-Davis Div of Pfizer Inc
Usage: LYRICA is indicated for managing neuropathic pain related to diabetic peripheral neuropathy and spinal cord injury, postherpetic neuralgia, fibromyalgia, and as adjunctive therapy for partial-onset seizures in patients aged 1 month and older.
naprelan
(Naproxen Sodium)
ALMATICA PHARMA INC.
Usage: NAPRELAN Tablets are indicated for treating rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.
ofev
(nintedanib)
Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: OFEV is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases with a progressive phenotype, and to slow pulmonary function decline in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
orencia
(abatacept)
E.R. Squibb & Sons, L.L.C.
Usage: ORENCIA® is indicated for treating moderately to severely active rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis in patients aged 2 and older, active psoriatic arthritis in patients 2 years and older, and for prophylaxis of acute graft versus host disease in hematopoietic stem cell transplant recipients.
otrexup
(methotrexate)
Antares Pharma, Inc.
Usage: Otrexup is indicated for managing severe, active rheumatoid arthritis in adults and children with polyarticular juvenile idiopathic arthritis, as well as for the symptomatic control of severe psoriasis in adults unresponsive to other treatments. It is not for neoplastic diseases.

Musculoskeletal (Rheum/Ortho) drugs

ilaris

inveltys

krystexxa

lotemax sm

lupkynis

lyrica

naprelan

ofev

orencia

otrexup